股票/基金 实时行情 股吧

简称:浙江医药 代码:600216


会计年度:2004-09-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其中:关联交易3,677,998.962,639,043.451,038,955.5128.25
食品药4,269,176.243,503,783.19765,393.0517.93
原料药748,903,836.61696,048,140.3252,855,696.297.06
制剂药289,163,235.83206,509,971.0882,653,264.7528.58

会计年度:2004-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:抵销2,336,228.562,336,228.56----
食品销售3,952,573.673,305,174.84647,398.8316.38
原料药销售510,157,712.30474,001,342.0136,156,370.297.09
制剂药销售191,160,200.64143,655,045.9047,505,154.7424.85

会计年度:2003-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:抵消3,600,384.083,600,384.08----
食品销售8,682,374.677,179,725.971,502,648.7017.31
原料药销售756,494,398.26699,815,274.1656,679,124.107.49
制剂药销售371,307,657.99280,252,238.6691,055,419.3324.52

会计年度:2003-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
食品销售3,698,692.193,087,360.44611,331.7516.53
原料药销售447,721,615.85410,243,335.6337,478,280.228.37
制剂药销售180,707,960.95128,669,060.7752,038,900.1828.80

会计年度:2002-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,113,399,300.00863,903,900.00--22.40
减:抵销9,499,500.009,499,500.00----
食品销售8,952,300.006,736,000.002,216,300.0024.75
原料药销售749,777,800.00615,031,800.00134,746,000.0017.97
制剂药销售364,168,700.00251,635,500.00112,533,200.0030.90

    8/9 转到